New Ammo In The Battle Against Cancer – Context Therapeutics Sees Promising Results For Several Novel Drugs
August 17, 2022 at 11:38 AM EDT
Martin Lehr, Co-Founder and CEO of Contect Therapeutics, Inc (NASDAQ: CNTX), was a guest on Benzinga’s All Access on Aug 12, ...
